Literature DB >> 17518926

Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy.

A Leland Albright1, Kristen Thompson, Signe Carlos, M Beth Minnigh.   

Abstract

The aim of this study was to report concentrations of cerebrospinal fluid (CSF) baclofen in children undergoing chronic intrathecal baclofen (ITB) infusions. CSF baclofen concentrations were analyzed in 53 specimens obtained by intrathecal catheter aspiration from 43 participants (28 males, 15 females; range 3-44y, mean 16y [SD 8y 11mo]), with functioning baclofen pumps and catheters. Daily ITB doses ranged from 70 to 1395 microg per day (mean 607 microg per day [SD 363], median 575). Baclofen concentration was quantified by high-pressure liquid chromatography and confirmed by injection onto a gas chromatograph. CSF baclofen concentrations from children receiving either simple continuous or complex infusions ranged from 0.2 to 20.0 microg/ml (mean 4.64 microg/ml, median 3.3 microg/ml). CSF baclofen concentrations from children receiving simple continuous infusions ranged from 0.5 to 12.9 (mean 4.7 microg/ml, median 3.55 microg/ml). There was no correlation between ITB dosage and CSF baclofen concentration. We conclude that baclofen concentration can be measured to determine if baclofen is present in CSF. However, there appears to be no correlation between the ITB dose infused and the corresponding CSF baclofen level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17518926     DOI: 10.1111/j.1469-8749.2007.00423.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  2 in total

1.  Effect of intrathecal baclofen concentration on spasticity control: case series.

Authors:  April Saval; Anthony E Chiodo
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 2.  Role of Catheter's Position for Final Results in Intrathecal Drug Delivery. Analysis Based on CSF Dynamics and Specific Drugs Profiles.

Authors:  De Andres Jose; Perotti Luciano; Villanueva Vicente; Asensio Samper Juan Marcos; Fabregat-Cid Gustavo
Journal:  Korean J Pain       Date:  2013-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.